|
|
|
Volumn 19, Issue 3, 2002, Pages 1-46
|
|
NIH Consensus Statement on Management of Hepatitis C: 2002.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
RIBAVIRIN;
ACUTE DISEASE;
BIOPSY;
CHRONIC DISEASE;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
ENZYME IMMUNOASSAY;
EVIDENCE BASED MEDICINE;
GENETICS;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INCIDENCE;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MASS SCREENING;
METHODOLOGY;
NEEDS ASSESSMENT;
PATIENT SELECTION;
PREVALENCE;
PRIMARY PREVENTION;
SENSITIVITY AND SPECIFICITY;
STANDARD;
TREATMENT OUTCOME;
UNITED STATES;
VIROLOGY;
ACUTE DISEASE;
ANTIVIRAL AGENTS;
BIOPSY;
CHRONIC DISEASE;
EVIDENCE-BASED MEDICINE;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
IMMUNOENZYME TECHNIQUES;
INCIDENCE;
INTERFERON-ALPHA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MASS SCREENING;
NEEDS ASSESSMENT;
PATIENT SELECTION;
PREVALENCE;
PRIMARY PREVENTION;
RIBAVIRIN;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 1542350630
PISSN: 15530957
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (498)
|
|
References (0)
|